Choksi Laboratories [CHOKSILA] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison

Choksi Laboratories

BSE

Suraksha Diagnostic

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Choksi Laboratories wins in 6 metrics, Suraksha Diagnostic wins in 11 metrics, with 0 ties. Suraksha Diagnostic appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Choksi Laboratories	Suraksha Diagnostic	Better
P/E Ratio (TTM)	101.93	49.97	Suraksha Diagnostic
Price-to-Book Ratio	6.63	7.86	Choksi Laboratories
Debt-to-Equity Ratio	123.52	42.28	Suraksha Diagnostic
PEG Ratio	N/A	2.76	N/A
EV/EBITDA	16.17	25.33	Choksi Laboratories
Profit Margin (TTM)	3.52%	12.62%	Suraksha Diagnostic
Operating Margin (TTM)	10.90%	19.43%	Suraksha Diagnostic
EBITDA Margin (TTM)	10.90%	19.43%	Suraksha Diagnostic
Return on Equity	6.45%	15.14%	Suraksha Diagnostic
Return on Assets (TTM)	2.33%	9.54%	Suraksha Diagnostic
Free Cash Flow (TTM)	$40.91M	$213.35M	Suraksha Diagnostic
1-Year Return	191.98%	-24.69%	Choksi Laboratories
Price-to-Sales Ratio (TTM)	3.69	6.30	Choksi Laboratories
Enterprise Value	$1.86B	$17.28B	Suraksha Diagnostic
EV/Revenue Ratio	4.39	6.55	Choksi Laboratories
Gross Profit Margin (TTM)	85.53%	87.94%	Suraksha Diagnostic
Revenue per Share (TTM)	$61	$51	Choksi Laboratories
Earnings per Share (Diluted)	$2.20	$6.38	Suraksha Diagnostic
Beta (Stock Volatility)	0.16	N/A	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Choksi Laboratories vs Suraksha Diagnostic Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Choksi Laboratories	-0.34%	-1.92%	15.70%	98.51%	73.94%	144.17%
Suraksha Diagnostic	-1.13%	0.03%	0.21%	-3.07%	7.14%	-17.32%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Choksi Laboratories	191.98%	677.21%	1,917.89%	1,529.26%	937.50%	199.25%
Suraksha Diagnostic	-24.69%	-24.69%	-24.69%	-24.69%	-24.69%	-24.69%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Choksi Laboratories (CHOKSILA): View Full Stock Overview

Suraksha Diagnostic (SURAKSHA): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Choksi Laboratories vs Suraksha Diagnostic

Metric	CHOKSILA	SURAKSHA
Market Information
Market Cap i	₹1.56B	₹16.60B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	14,560	39,095
90 Day Avg. Volume i	10,119	30,103
Last Close	₹219.95	₹314.25
52 Week Range	₹56.16 - ₹236.70	₹231.00 - ₹449.00
% from 52W High	-7.08%	-30.01%
All-Time High	₹236.70 (Aug 20, 2025)	₹449.00 (Dec 02, 2024)
% from All-Time High	-7.08%	-30.01%
Growth Metrics
Quarterly Revenue Growth	0.05%	0.21%
Quarterly Earnings Growth	-0.09%	0.18%
Financial Health
Profit Margin (TTM) i	0.04%	0.13%
Operating Margin (TTM) i	0.11%	0.19%
Return on Equity (TTM) i	0.06%	0.15%
Debt to Equity (MRQ) i	123.52	42.28
Cash & Liquidity
Book Value per Share (MRQ)	₹33.82	₹40.56
Cash per Share (MRQ)	₹0.88	₹3.86
Operating Cash Flow (TTM) i	₹51.38M	₹365.13M
Levered Free Cash Flow (TTM) i	₹15.23M	₹318.24M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Choksi Laboratories vs Suraksha Diagnostic

Metric	CHOKSILA	SURAKSHA
Price Ratios
P/E Ratio (TTM) i	101.93	49.97
Forward P/E i	N/A	33.62
PEG Ratio i	N/A	2.76
Price to Sales (TTM) i	3.69	6.30
Price to Book (MRQ) i	6.63	7.86
Market Capitalization
Market Capitalization i	₹1.56B	₹16.60B
Enterprise Value i	₹1.86B	₹17.28B
Enterprise Value Metrics
Enterprise to Revenue i	4.39	6.55
Enterprise to EBITDA i	16.17	25.33
Risk & Other Metrics
Beta i	0.16	N/A
Book Value per Share (MRQ) i	₹33.82	₹40.56

Financial Statements Comparison: Choksi Laboratories vs Suraksha Diagnostic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	CHOKSILA	SURAKSHA
Revenue/Sales i	₹114.00M	₹725.86M
Cost of Goods Sold i	₹16.49M	₹87.51M
Gross Profit i	₹97.50M	₹638.36M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹18.64M	₹133.78M
EBITDA i	₹35.45M	₹237.66M
Pre-Tax Income i	₹12.59M	₹124.69M
Income Tax i	₹3.38M	₹32.94M
Net Income (Profit) i	₹9.21M	₹91.75M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	CHOKSILA	SURAKSHA
Cash & Equivalents i	₹6.12M	₹22.47M
Total Current Assets i	₹163.21M	₹471.53M
Total Current Liabilities i	₹238.75M	₹427.17M
Long-Term Debt i	₹159.63M	₹741.03M
Total Shareholders Equity i	₹236.05M	₹2.10B
Retained Earnings i	N/A	₹1.54B
Property, Plant & Equipment i	₹471.35M	₹1.38B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	CHOKSILA	SURAKSHA
Operating Cash Flow i	N/A	₹148.52M
Capital Expenditures i	N/A	₹-123.19M
Free Cash Flow i	N/A	₹64.63M
Debt Repayment i	N/A	₹-7.29M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	CHOKSILA	SURAKSHA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	14,560	39,095
Average Daily Volume (90 Day) i	10,119	30,103
Shares Outstanding i	6.97M	52.08M
Float Shares i	3.37M	21.54M
% Held by Insiders i	0.56%	0.62%
% Held by Institutions i	0.00%	0.23%

Dividend Analysis & Yield Comparison: Choksi Laboratories vs Suraksha Diagnostic

Metric	CHOKSILA	SURAKSHA
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Choksi Laboratories [CHOKSILA] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison